Quantitative and Volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response After Transcatheter Arterial...

Overview

Journal J Vasc Interv Radiol

Specialties Cardiology & Vascular Diseases
Radiology

Date 2012 Nov 27

PMID 23177109

Citations 64

Authors

MingDe Lin

Olivier Pellerin

Nikhil Bhagat

Pramod P Rao

Romaric Loffroy

Roberto Ardon

Benoit Mory

Diane K Reyes

Jean-Francois Geschwind

Affiliations

Soon will be listed here.

Abstract

Purpose: To show that hepatic tumor volume and enhancement pattern measurements can be obtained in a time-efficient and reproducible manner on a voxel-by-voxel basis to provide a true three-dimensional (3D) volumetric assessment.

Materials And Methods: Magnetic resonance (MR) imaging data obtained from 20 patients recruited for a single-institution prospective study were retrospectively evaluated. All patients had a diagnosis of hepatocellular carcinoma (HCC) and underwent drug-eluting beads (DEB) transcatheter arterial chemoembolization for the first time. All patients had undergone contrast-enhanced MR imaging before and after DEB transcatheter arterial chemoembolization; poor image quality excluded 3 patients, resulting in a final count of 17 patients. Volumetric RECIST (vRECIST) and quantitative EASL (qEASL) were measured, and segmentation and processing times were recorded.

Results: There were 34 scans analyzed. The time for semiautomatic segmentation was 65 seconds±33 (range, 40-200 seconds). vRECIST and qEASL of each tumor were computed<1 minute for each.

Conclusions: Semiautomatic quantitative tumor enhancement (qEASL) and volume (vRECIST) assessment is feasible in a workflow-efficient time frame. Clinical correlation is necessary, but vRECIST and qEASL could become part of the assessment of intraarterial therapy for interventional radiologists.

Citing Articles

AFP-DIAM Score to Predict Survival in Patients with Hepatocellular Carcinoma Before TACE: A French Multicenter Study.

Rebillard E, De Abreu N, Buchard B, Muti L, Boulin M, Pereira B Dig Dis Sci. 2024; 69(11):4259-4267.

PMID: 39322806 DOI: 10.1007/s10620-024-08639-8.

Comparison of automated with manual 3D qEASL assessment based on MR imaging in hepatocellular carcinoma treated with conventional TACE.

Yang T, Gong X, Wang L, Zhang S, Shi Y, Ren H Abdom Radiol (NY). 2024; 50(3):1180-1188.

PMID: 39297930 DOI: 10.1007/s00261-024-04571-7.

Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases.

Ghabili K, Windham-Herman A, Konstantinidis M, Murali N, Borde T, Adam L Ann Hepatol. 2024; 29(6):101529.

PMID: 39033928 PMC: 11558520. DOI: 10.1016/j.aohep.2024.101529.

Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.

Sobirey R, Matuschewski N, Gross M, Lin M, Kao T, Kasolowsky V Eur Radiol. 2024; 35(1):73-83.

PMID: 39033181 DOI: 10.1007/s00330-024-10955-6.

Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters.

Mohseni A, Baghdadi A, Madani S, Shahbazian H, Mirza-Aghazadeh-Attari M, Borhani A Abdom Radiol (NY). 2024; 49(8):2595-2605.

PMID: 38546828 DOI: 10.1007/s00261-024-04257-0.

References

Miller A, Hoogstraten B, STAQUET M, Winkler A . Reporting results of cancer treatment. Cancer. 1981; 47(1):207-14. DOI: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. View

Gwyther S, Schwartz L . How to assess anti-tumour efficacy by imaging techniques. Eur J Cancer. 2007; 44(1):39-45. DOI: 10.1016/j.ejca.2007.10.010. View

Tran L, Brown M, Goldin J, Yan X, Pais R, McNitt-Gray M . Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol. 2004; 11(12):1355-60. DOI: 10.1016/j.acra.2004.09.004. View

Pellerin O, Lin M, Bhagat N, Ardon R, Mory B, Geschwind J . Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models. Acad Radiol. 2012; 20(1):115-21. PMC: 3575098. DOI: 10.1016/j.acra.2012.07.011. View

Obuchowski N . How many observers are needed in clinical studies of medical imaging?. AJR Am J Roentgenol. 2004; 182(4):867-9. DOI: 10.2214/ajr.182.4.1820867. View

Edeline J, Boucher E, Rolland Y, Vauleon E, Pracht M, Perrin C . Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma. Cancer. 2011; 118(1):147-56. DOI: 10.1002/cncr.26255. View

Kamel I, Liapi E, Reyes D, Zahurak M, Bluemke D, Geschwind J . Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology. 2009; 250(2):466-73. PMC: 6944072. DOI: 10.1148/radiol.2502072222. View

Monsky W, Kim I, Loh S, Li C, Greasby T, Deutsch L . Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol. 2010; 195(5):1220-30. DOI: 10.2214/AJR.09.3964. View

Zhao B, James L, Moskowitz C, Guo P, Ginsberg M, Lefkowitz R . Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology. 2009; 252(1):263-72. PMC: 2797680. DOI: 10.1148/radiol.2522081593. View

10.

Lim H, Han J . Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures. Abdom Imaging. 2002; 27(2):168-79. DOI: 10.1007/s00261-001-0093-9. View

11.

Reyes D, Vossen J, Kamel I, Azad N, Wahlin T, Torbenson M . Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009; 15(6):526-32. PMC: 4390059. DOI: 10.1097/PPO.0b013e3181c5214b. View

12.

Keil S, Plumhans C, Behrendt F, Stanzel S, Suehling M, Muhlenbruch G . Semi-automated quantification of hepatic lesions in a phantom. Invest Radiol. 2008; 44(2):82-8. DOI: 10.1097/RLI.0b013e3181911ffa. View

13.

Curran S, Muellner A, Schwartz L . Imaging response assessment in oncology. Cancer Imaging. 2006; 6:S126-30. PMC: 1805076. DOI: 10.1102/1470-7330.2006.9039. View

14.

Cademartiri F, Luccichenti G, Maffei E, Fusaro M, Palumbo A, Soliani P . Imaging for oncologic staging and follow-up: review of current methods and novel approaches. Acta Biomed. 2008; 79(2):85-91. View

15.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

16.

Miller F, Keppke A, Reddy D, Huang J, Jin J, Mulcahy M . Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol. 2007; 188(3):776-83. DOI: 10.2214/AJR.06.0707. View

17.

Lee S, Kim S, Lee J, Im S, Bang Y, Kim W . Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer. Abdom Imaging. 2008; 34(4):430-40. DOI: 10.1007/s00261-008-9420-8. View

18.

Belton A, Saini S, Liebermann K, Boland G, Halpern E . Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements. Clin Radiol. 2003; 58(4):311-4. DOI: 10.1016/s0009-9260(02)00577-9. View

19.

Galizia M, Tore H, Chalian H, McCarthy R, Salem R, Yaghmai V . MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques. Acad Radiol. 2011; 19(1):48-54. DOI: 10.1016/j.acra.2011.09.005. View

20.

Fabel M, Biederer J, Jochens A, Bornemann L, Soza G, Heller M . Semi-automated volumetric analysis of artificial lymph nodes in a phantom study. Eur J Radiol. 2010; 80(3):e451-7. DOI: 10.1016/j.ejrad.2010.10.019. View